Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Increased expression of blood muscarinic receptors in patients with reflex syncope.

Beutelstetter M, Livolsi A, Greney H, Helms P, Schmidt-Mutter C, De Melo C, Roul G, Zores F, Bolle A, Dali-Youcef N, Beaugey M, Simon A, Niederhoffer N, Regnard J, Bouhaddi M, Adamopoulos C, Schaeffer M, Sauleau E, Bousquet P.

PLoS One. 2019 Jul 18;14(7):e0219598. doi: 10.1371/journal.pone.0219598. eCollection 2019.

2.

Effects of imidazoline-like drugs on liver and adipose tissues, and their role in preventing obesity and associated cardio-metabolic disorders.

Aubertin G, Weiss M, Traversi F, Benameur D, Choquet P, Dali-Youcef N, Pons F, Sigrist S, Greney H, Monassier L, Bousquet P, Niederhoffer N.

Int J Obes (Lond). 2019 Nov;43(11):2163-2175. doi: 10.1038/s41366-019-0342-z. Epub 2019 Mar 29.

PMID:
30926950
3.

Metabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases.

Ameline A, Greney H, Monassier L, Raul JS, Kintz P.

J Anal Toxicol. 2019 May 1;43(4):321-324. doi: 10.1093/jat/bky097.

PMID:
30476158
4.

Expression of Circulating Muscarinic Receptors in Infants With Severe Idiopathic Life-Threatening Events.

Adamopoulos C, Greney H, Beutelstetter M, Bousquet P, Livolsi A.

JAMA Pediatr. 2016 Jul 1;170(7):707-8. doi: 10.1001/jamapediatrics.2015.4762. No abstract available.

PMID:
27159641
5.

Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance.

Weiss M, Bouchoucha S, Aiad F, Ayme-Dietrich E, Dali-Youcef N, Bousquet P, Greney H, Niederhoffer N.

Am J Physiol Endocrinol Metab. 2015 Jul 15;309(2):E95-104. doi: 10.1152/ajpendo.00021.2015. Epub 2015 May 26.

6.

Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.

Gasparik V, Greney H, Schann S, Feldman J, Fellmann L, Ehrhardt JD, Bousquet P.

J Med Chem. 2015 Jan 22;58(2):878-87. doi: 10.1021/jm501456p. Epub 2014 Dec 31.

PMID:
25521963
7.

A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats.

Fellmann L, Regnault V, Greney H, Gasparik V, Muscat A, Max JP, Gigou L, Oréa V, Chetrite G, Pizard A, Niederhoffer N, Julien C, Lacolley P, Fève B, Bousquet P.

J Pharmacol Exp Ther. 2013 Sep;346(3):370-80. doi: 10.1124/jpet.113.205328. Epub 2013 Jul 1. Erratum in: J Pharmacol Exp Ther. 2013 Oct;347(1):249.

PMID:
23818682
8.

Methylation of imidazoline related compounds leads to loss of α₂-adrenoceptor affinity. Synthesis and biological evaluation of selective I₁ imidazoline receptor ligands.

Schann S, Greney H, Gasparik V, Dontenwill M, Rascente C, Lacroix G, Monassier L, Bruban V, Feldman J, Ehrhardt JD, Bousquet P.

Bioorg Med Chem. 2012 Aug 1;20(15):4710-5. doi: 10.1016/j.bmc.2012.06.008. Epub 2012 Jun 9.

PMID:
22750139
9.

G-protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands.

Yoro Sy G, Urosevic D, Fellmann L, Greney H, Bousquet P, Feldman J.

J Hypertens. 2008 May;26(5):1025-32. doi: 10.1097/HJH.0b013e3282f5ed44.

PMID:
18398346
10.

sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart.

Monassier L, Manoury B, Bellocq C, Weissenburger J, Greney H, Zimmermann D, Ehrhardt JD, Jaillon P, Baró I, Bousquet P.

J Pharmacol Exp Ther. 2007 Jul;322(1):341-50. Epub 2007 Apr 25.

PMID:
17460149
11.

LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptors.

Urosevic D, Schann S, Ehrhardt JD, Bousquet P, Greney H.

Br J Pharmacol. 2004 Jun;142(3):609-17. Erratum in: Br J Pharmacol. 2004 Aug;142(8):1368. Dragan, Urosevic [corrected to Urosevic, Dragan]; Stephan, Schann [corrected to Schann, Stephan]; Jean-Daniel, Ehrhardt [corrected to Ehrhardt, Jean-Daniel]; Pascal, Bousquet [corrected to Bousquet, Pascal]; Hugues, Greney [corrected to Greney, Hugues].

12.

I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells.

Dupuy L, Urosevic D, Greney H, Quaglia W, Pigini M, Brasili L, Dontenwill M, Bousquet P.

Cell Death Differ. 2004 Sep;11(9):1049-52. No abstract available.

13.

Chronic treatment with rilmenidine in spontaneously hypertensive rats: differences between two schedules of administration.

Monassier L, Greney H, Thomas L, Bousquet P.

J Cardiovasc Pharmacol. 2004 Mar;43(3):394-401.

PMID:
15076223
14.

IRAS is an anti-apoptotic protein.

Dontenwill M, Piletz JE, Chen M, Baldwin J, Pascal G, Ronde P, Dupuy L, Greney H, Takeda K, Bousquetd P.

Ann N Y Acad Sci. 2003 Dec;1009:400-12.

PMID:
15028619
15.

I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going?

Bousquet P, Greney H, Bruban V, Schann S, Ehrhardt JD, Monassier L, Feldman J.

Ann N Y Acad Sci. 2003 Dec;1009:228-33. Review.

PMID:
15028592
16.

IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells.

Dontenwill M, Pascal G, Piletz JE, Chen M, Baldwin J, Rondé P, Dupuy L, Urosevic D, Greney H, Takeda K, Bousquet P.

Cell Death Differ. 2003 Aug;10(8):933-5. No abstract available.

17.

[125I]2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptors.

Greney H, Urosevic D, Schann S, Dupuy L, Bruban V, Ehrhardt JD, Bousquet P, Dontenwill M.

Mol Pharmacol. 2002 Jul;62(1):181-91.

PMID:
12065769
18.

Differential sensitivity to inverse agonists of GABA(A)/benzodiazepine receptors in rats with genetic absence-epilepsy.

Vergnes M, Boehrer A, He X, Greney H, Dontenwill M, Cook J, Marescaux C.

Epilepsy Res. 2001 Nov;47(1-2):43-53.

PMID:
11673020
19.

Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.

Bruban V, Feldman J, Greney H, Dontenwill M, Schann S, Jarry C, Payard M, Boutin J, Scalbert E, Pfeiffer B, Renard P, Vanhoutte P, Bousquet P.

Br J Pharmacol. 2001 May;133(2):261-6.

20.

Imidazoline receptors in cardiovascular and metabolic diseases.

Bousquet P, Dontenwill M, Greney H, Feldman J.

J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S21-5. Review.

PMID:
11346216
21.

Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.

Greney H, Ronde P, Magnier C, Maranca F, Rascente C, Quaglia W, Giannella M, Pigini M, Brasili L, Lugnier C, Bousquet P, Dontenwill M.

Mol Pharmacol. 2000 Jun;57(6):1142-51.

PMID:
10825384
22.

Participation of imidazoline receptors and alpha(2-)-adrenoceptors in the central hypotensive effects of imidazoline-like drugs.

Bousquet P, Bruban V, Schann S, Greney H, Ehrhardt JD, Dontenwill M, Feldman J.

Ann N Y Acad Sci. 1999 Jun 21;881:272-8. Review.

PMID:
10415925
23.

Evidence for presynaptic high affinity imidazoline-specific binding sites in the bovine brainstem.

Heemskerk FM, Dontenwill M, Greney H, Vonthron C, Bousquet P.

Ann N Y Acad Sci. 1999 Jun 21;881:185-8. No abstract available.

PMID:
10415913
24.

Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors.

Dontenwill M, Vonthron C, Greney H, Magnier C, Heemskerk F, Bousquet P.

Ann N Y Acad Sci. 1999 Jun 21;881:123-34.

PMID:
10415908
25.

An unexpected central hypertensive effect of the new imidazoline compound benazoline.

Bruban V, Feldman J, Dontenwill M, Greney H, Brasili L, Giannella M, Pigini M, Bousquet P.

Ann N Y Acad Sci. 1999 Jun 21;881:102-5. No abstract available.

PMID:
10415903
26.

Transfected cells expressing the three subtypes of alpha 2-adrenergic receptors lack I1-imidazoline binding sites.

Ordener C, Greney H, Devedjian J, Dontenwill M, Bousquet P, Parini A.

Ann N Y Acad Sci. 1999 Jun 21;881:59-60. No abstract available.

PMID:
10415897
27.

Coexpression of imidazoline receptors and alpha 2-adrenoceptors in neuroglial cell line NG 108,15.

Greney H, Heemskerk F, Vonthron C, Magnier C, Bousquet P, Dontenwill M.

Ann N Y Acad Sci. 1999 Jun 21;881:54-8. No abstract available.

PMID:
10415896
28.

Does a second generation of centrally acting antihypertensive drugs really exist?

Feldman J, Greney H, Monassier L, Vonthron C, Bruban V, Dontenwill M, Bousquet P.

J Auton Nerv Syst. 1998 Oct 15;72(2-3):94-7. Review.

PMID:
9851557
29.

Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem.

Heemskerk FM, Dontenwill M, Greney H, Vonthron C, Bousquet P.

J Neurochem. 1998 Nov;71(5):2193-202.

30.

I1-imidazoline receptors: an update.

Bousquet P, Dontenwill M, Greney H, Feldman J.

J Hypertens Suppl. 1998 Aug;16(3):S1-5. Review.

PMID:
9747903
31.

Further biochemical characterization of imidazoline binding sites from the human brainstem.

Greney H, Dontenwill M, Vonthron C, Bousquet P.

Fundam Clin Pharmacol. 1997;11(1):63-7.

PMID:
9182078
32.

Binding of new cirazoline derivative to imidazoline receptors from human brain.

Dontenwill M, Ehrhardt JD, Senecheau P, Molines A, Greney H, Bousquet P.

Neurochem Int. 1997 Jan;30(1):9-16.

PMID:
9116592
33.

Polyclonal anti-idiotypic antibodies to idazoxan and their interaction with human brain imidazoline binding sites.

Bennai F, Greney H, Vonthron C, Bousquet P, Dontenwill M.

Eur J Pharmacol. 1996 Jun 13;306(1-3):211-8.

PMID:
8813634
34.

Imidazoline receptors and cardiovascular regulations. A statement.

Bousquet P, Greney H, Bennai F, Feldman J, Stutzmann J, Belcourt A, Dontenwill M.

Ann N Y Acad Sci. 1995 Jul 12;763:526-30. Review. No abstract available.

PMID:
7677370
35.

Human cerebral imidazoline binding sites. Further biochemical investigations.

Greney H, Dontenwill M, Bricca G, Belcourt A, Bousquet P.

Ann N Y Acad Sci. 1995 Jul 12;763:523-5. No abstract available.

PMID:
7677369
36.

Structure-affinity relationship of cirazoline derivatives for idazoxan imidazoline-specific sites in the human cerebral cortex and the rabbit kidney.

Brasili L, Pigini M, Ehrhardt JD, Molines A, Greney H, Bousquet P, Dontenwill M.

Ann N Y Acad Sci. 1995 Jul 12;763:149-52. No abstract available.

PMID:
7677323
37.

Antiidiotypic antibodies as tools to study imidazoline receptors.

Bennai F, Greney H, Molines A, Bousquet P, Dontenwill M.

Ann N Y Acad Sci. 1995 Jul 12;763:140-8. Review. No abstract available.

PMID:
7677322
38.

Heterogeneity of imidazoline binding sites revealed by a cirazoline derivative.

Greney H, Molines A, Bousquet P, Dontenwill M.

Eur J Pharmacol. 1994 Dec 27;271(2-3):533-6.

PMID:
7705454
39.

Role of imidazoline receptors in cardiovascular regulation.

Dontenwill M, Tibiriça E, Greney H, Bennaï F, Feldman J, Stutzmann J, Bricca G, Belcourt A, Bousquet P.

Am J Cardiol. 1994 Dec 22;74(13):3A-6A. Review.

PMID:
7998582
40.

Isolation of a human cerebral imidazoline-specific binding protein.

Greney H, Bennai F, Molines A, Belcourt A, Dontenwill M, Bousquet P.

Eur J Pharmacol. 1994 Nov 14;265(1-2):R1-2.

PMID:
7883019
41.

Characterization of imidazoline binding protein(s) solubilized from human brainstem: studies with [3H]idazoxan and [3H]clonidine.

Greney H, Bricca G, Dontenwill M, Stutzmann J, Bousquet P, Belcourt A.

Neurochem Int. 1994 Aug;25(2):183-91.

PMID:
7994199
42.

Human brain imidazoline receptors: further characterization with [3H]clonidine.

Bricca G, Greney H, Zhang J, Dontenwill M, Stutzmann J, Belcourt A, Bousquet P.

Eur J Pharmacol. 1994 Jan 1;266(1):25-33.

PMID:
8137880
43.

Relevance of the use of [3H]-clonidine to identify imidazoline receptors in the rabbit brainstem.

Bricca G, Zhang J, Greney H, Dontenwill M, Stutzmann J, Belcourt A, Bousquet P.

Br J Pharmacol. 1993 Dec;110(4):1537-43.

44.

The imidazoline receptors and the central regulation of the arterial blood pressure: a minireview.

Tibiriça E, Bricca G, Dontenwill M, Feldman J, Greney H, Belcourt A, Stutzmann J, Bousquet P.

Mem Inst Oswaldo Cruz. 1993 Apr-Jun;88(2):317-25. Review.

45.

Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortex.

Bricca G, Greney H, Dontenwill-Kieffer M, Zhang J, Belcourt A, Bousquet P.

Neurochem Int. 1993 Feb;22(2):153-63.

PMID:
8439769
46.

Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.

Bousquet P, Feldman J, Tibirica E, Bricca G, Greney H, Dontenwill M, Stutzmann J, Belcourt A.

Am J Hypertens. 1992 Apr;5(4 Pt 2):47S-50S. Review.

PMID:
1350728
47.

From the alpha 2-adrenoceptors to the imidazoline preferring receptors.

Bousquet P, Bricca G, Dontenwill M, Feldman J, Greney H, Belcourt A, Stutzmann J, Tibiriça E.

Fundam Clin Pharmacol. 1992;6 Suppl 1:15S-21S. Review. No abstract available.

PMID:
1324210
48.

[Involution of cancers in dogs by autograft after passage on rabbits].

Spehler H, Greney H, Auer V, Le Gal Y.

J Chir (Paris). 1971 Oct;102(4):365-7. French. No abstract available.

PMID:
4110266
49.

[Increased serum alpha1-globulins in epithelioma].

Greney H, Greney J, Spehler H, Le Gal Y.

Presse Med. 1971 May 29;79(27):1238. French. No abstract available.

PMID:
4104166

Supplemental Content

Loading ...
Support Center